MiNK Therapeutics (INKT) Institutional Ownership $9.03 -0.20 (-2.17%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$9.12 +0.09 (+0.94%) As of 03/28/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for MiNK Therapeutics (NASDAQ:INKT)CurrentInstitutional OwnershipPercentage2.87%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$214.64KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$55.06K Get INKT Insider Trade Alerts Want to know when executives and insiders are buying or selling MiNK Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data INKT Institutional Buying and Selling by Quarter Remove Ads MiNK Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 Renaissance Technologies LLC101,707$71K0.0%-4.7%2.566% 2/12/2025 Geode Capital Management LLC96,113$67K0.0%-1.9%2.427% 2/7/2025 HighTower Advisors LLC50,676$35K0.0%-2.0%1.280% 8/9/2024 Renaissance Technologies LLC127,841$121K0.0%+21.5%0.368% 11/14/2023 Oracle Investment Management Inc.36,898$41K0.0%-26.9%0.107% 8/14/2023 Oracle Investment Management Inc.50,461$106K0.1%N/A0.146% 8/14/2023 Deep Track Capital LP324,867$682K0.0%N/A0.941% 8/11/2023 Artal Group S.A.228,216$479K0.0%-21.2%0.663% 7/27/2023 Virtu Financial LLC14,232$30K0.0%N/A0.041% 2/10/2023 StoneX Group Inc.17,821$47K0.0%N/A0.053% 11/4/2022First Republic Investment Management Inc.81,500$172K0.0%N/A0.243% 2/15/2022 Sofinnova Investments Inc.345,499$1.54M0.1%N/A1.031% (Data available from 1/1/2016 forward)Remove Ads INKT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of INKT shares? During the previous two years, the following institutional investors and hedge funds held shares of MiNK Therapeutics shares: Deep Track Capital LP ($682K), Artal Group S.A. ($479K), Renaissance Technologies LLC ($71K), Geode Capital Management LLC ($67K), Oracle Investment Management Inc. ($41K), and HighTower Advisors LLC ($35K), and Virtu Financial LLC ($30K).Learn more on INKT's institutional investors. What percentage of MiNK Therapeutics stock is owned by institutional investors? 2.87% of MiNK Therapeutics stock is owned by institutional investors. Learn more on INKT's institutional investor holdings. Which institutional investors have been buying MiNK Therapeutics stock? The following institutional investors have purchased MiNK Therapeutics stock in the last 24 months: Deep Track Capital LP ($324.87K), Oracle Investment Management Inc. ($50.46K), Renaissance Technologies LLC ($22.61K), and Virtu Financial LLC ($14.23K). How much institutional buying is happening at MiNK Therapeutics? Institutional investors have bought a total of 412,173 shares in the last 24 months. This purchase volume represents approximately $8.40M in transactions. Which MiNK Therapeutics major shareholders have been selling company stock? The following institutional investors have sold MiNK Therapeutics stock in the last 24 months: Artal Group S.A. ($61.37K), Oracle Investment Management Inc. ($13.56K), Renaissance Technologies LLC ($4.98K), Geode Capital Management LLC ($1.87K), and HighTower Advisors LLC ($1.05K). How much institutional selling is happening at MiNK Therapeutics? Institutional investors have sold a total of 82,835 shares in the last 24 months. This volume of shares sold represents approximately $1.49M in transactions. Related Companies Alector Institutional Ownership Cassava Sciences Institutional Ownership Lexeo Therapeutics Institutional Ownership Telomir Pharmaceuticals Institutional Ownership ProQR Therapeutics Institutional Ownership Genelux Institutional Ownership Enanta Pharmaceuticals Institutional Ownership Eupraxia Pharmaceuticals Institutional Ownership Instil Bio Institutional Ownership Sagimet Biosciences Institutional Ownership This page (NASDAQ:INKT) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiNK Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiNK Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
